what has changed is the CEO has spread her risk by taking up a role at another biotech - so I think big funds are doing the same by offloading some of their risk.
I stay long term bullish by without any real catalysts now until q3/q4 I remain hopeful of grabbing a few shares around $1
Ann: Opthea Finalizes Ph 3 Study Designs and Startup Activities, page-44
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.8¢ |
Change
0.028(4.37%) |
Mkt cap ! $812.5M | |||
| Open | High | Low | Value | Volume |
| 62.0¢ | 66.5¢ | 62.0¢ | $1.518M | 2.359M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 64315 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 3995 | 2 |
View Market Depth
| Last trade - 14.29pm 18/09/2024 (20 minute delay) ? |
| OPT (ASX) Chart |